GLP-1 RAs slapped with ileus warning after TGA investigation
New safety warnings about the risk of ileus have been added to all GLP-1 receptor agonists following a TGA investigation into local reports of the…
Tag: Endocrinology – Diabetes
‘Little to no risk’ of birth defects with metformin in early pregnancy: study
Pregnant women with type 2 diabetes can safely use metformin in the first trimester, according to US epidemiologists who report no increased risk for congenital…
Watch for retained gastric contents with periprocedural GLP-1 RA use: new guidance
Patients taking GLP-1 receptor agonists within four weeks of anaesthesia for non-endoscopic procedures should be considered non-fasted, according to new guidance. Doctors are also advised…
How Novo Nordisk lobbied AHPRA and the TGA to get compounded semaglutide banned
More than a year before the Federal Government announced its compounding ban, the pharmaceutical giant Novo Nordisk was making complaints to AHPRA about pharmacies compounding…
Why did health officials restrict GLP-1 RA prescribing? Here’s the PBAC review behind the decision
What sparked the Department of Health and Aged Care decision to change prescribing rules for type 2 diabetes medications on the PBS? The 1 June…
‘Regrettable, if understandable’: PBS tightens GLP-1 RA prescribing rules
Doctors prescribing GLP-1 receptor agonists now require telephone or electronic authority when initiating therapy for all PBS indications. On 1 June, health officials tightened the…
Govt to ban semaglutide compounding from October amid patient safety fears
The TGA is banning pharmacists from compounding semaglutide and other GLP-1 receptor agonists, starting 1 October. About 20,000 patients are currently using compounded semaglutide for…
GDM linked to doubled NAFLD risk in offspring: review
Mothers with a history of gestational diabetes have a 50% higher risk of subsequent non-alcoholic fatty liver disease, while the risk is more than doubled…
GPs billing for point-of-care HbA1c tests risk breaking Medicare rules: RACGP
GPs have claimed thousands of rebates for point-of-care HbA1c tests even though no GP practice has met a mandatory accreditation rule, the RACGP says. The…
Nearly 100% of patients using insulin miss a bolus dose each fortnight: study
Missing two basal or four bolus insulin doses in a fortnight is linked with a clinically significant >5% decrease in time with glucose levels in…
